Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Status:
Not yet recruiting

Trial end date:
2024-08-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy of APSCTC compared to two active drugs in acute pain relief.

Phase 3

Apsen Farmaceutica S.A.

Tramadol